Envestnet Portfolio Solutions Inc. Sells 1,343 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Envestnet Portfolio Solutions Inc. lessened its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 14,280 shares of the company's stock after selling 1,343 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in HCA Healthcare were worth $4,934,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the stock. Atwood & Palmer Inc. acquired a new position in shares of HCA Healthcare in the first quarter valued at approximately $28,000. Whipplewood Advisors LLC acquired a new stake in HCA Healthcare in the fourth quarter valued at $31,000. Tidemark LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $36,000. Legacy Investment Solutions LLC increased its position in HCA Healthcare by 99.0% in the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after acquiring an additional 95 shares during the period. Finally, MV Capital Management Inc. grew its holdings in HCA Healthcare by 31.8% during the first quarter. MV Capital Management Inc. now owns 199 shares of the company's stock worth $69,000 after acquiring an additional 48 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insider Buying and Selling

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Stock Up 0.3%

Shares of NYSE HCA traded up $1.28 during mid-day trading on Monday, hitting $378.78. The company had a trading volume of 1,098,022 shares, compared to its average volume of 1,468,686. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a market capitalization of $91.12 billion, a PE ratio of 16.26, a price-to-earnings-growth ratio of 1.30 and a beta of 1.49. The firm has a 50-day simple moving average of $362.30 and a two-hundred day simple moving average of $334.94. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. HCA Healthcare's quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the prior year, the firm posted $5.36 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.76%. HCA Healthcare's payout ratio is currently 12.81%.

Analyst Ratings Changes

A number of analysts recently commented on the company. Royal Bank Of Canada increased their price objective on HCA Healthcare from $376.00 to $404.00 and gave the company an "outperform" rating in a research note on Monday. Morgan Stanley set a $410.00 price objective on HCA Healthcare and gave the company an "equal weight" rating in a research report on Monday, June 9th. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Finally, Stephens raised HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Seven research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $394.33.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.